Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > OSC and IIROC appeal for tips on abusive trading

<< Previous

Bullboard Posts

Next >>

Comment by luvhorseson Dec 19, 2020 7:05pm

145 Views

Post# 32147990

RE:OSC and IIROC appeal for tips on abusive trading

For me, this is a bit too late (as I sold all of my AGN shares)but it's not too late for the long here....check on their PP that was done back in APril/May!!! Funken got many of us with it....remember, when they Halted the stock only to release the news about a PP!!! Funken crooks!!!

I sure hope that AGN gets their A$$ kicked!!! Bring on the teens...never mind .20!!!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China